JET 2024 Program Detail
Session No LBCT 1
Friday, June 14, 2024, 08:00-09:00 Hall A
Late Breaking Clinical Trials #1English
Osamu Iida
Sabine Steiner
Masahiko Fujihara
Ralf Langhoff
Kazunori Horie
Brian DeRubertis
Steven Kum

THEME
Language
MODERATOR
MODERATOR
PANEL
PANEL
PANEL
PANEL
PANELTime

Speech

QA

(min)

(min)

08:00-

5

308:08-5

3

08:16-

5

3

08:24-

5

3

08:32-

5

3

08:40-

5

308:4853

Title and Speaker
One-year outcomes following a novel drug-eluting balloon“Luminor” for femoropopliteal lesion ~ SOL JAPAN Study~
Yoshimitsu Soga
Two-years result from the REAL-DES study
Tsuyoshi Shibata
24-month results from SELUTION SFA Japan trial -Safety andefficacy of a novel sirolimus-coated balloon for the treatmentof femoropopliteal lesions in Japanese populationOsamu Iida
FINAL 5-year data of the T.I.N.T.I.N. Trial: Luminor DCB andinvolution stent in TASC C and D femoropopliteal
atherosclerotic disease
Koen Deloose
Three-year result from the CAULIFLOWER study
Naoki Fujimura
Effectiveness and Safety of Mechanical Thrombectomy andThrombo-aspiration for Patients with Acute Limb Ischemia:
a Systematic Review and Meta-analysis
Yann Gouëffic
Safety of the orbital atherectomy in FP lesions:
Preliminary result of the KAIZEN trial
Hiroyoshi Yokoi

JET 2024 Program Detail
Session No A1
Friday, June 14, 2024, 9:10-10:10 Hall A
Theme
PAD Main Live Demonstration #1
Sub-theme
Leave the right thing behind
Co-sponsor: Cook Medical Japan G.K. / KANEKA MEDICAL PRODUCTS.
Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
Operator
Tokyo Bay Medical CenterEnglish
Osamu Iida
Hiroyoshi Yokoi
Tatsuro Takei
Yann Gouëffic
Sabine Steiner
Jackie Pei Ho
Tomoyasu Sato
Shigeo Ichihashi
Shannon D. Thomas
Brian DeRubertis
Tatsuya Nakama
CASE 01

Theme;

Short
LectureSpeech(min)
1.

5

2.

5

3.

5Title and Speaker
The 3-year result of the REALDES study
Tsuyoshi Shibata
Durable results with Zilver PTX stent implantation forcomplex femoropopliteal disease: insights from clinical
trials and daily practice
Sabine Steiner
Deciphering PTX Safety: Comprehensive Insights fromMulti-Patient Data Analyses
Yann GouëfficJET 2024 Program Detail
Session No A2
Friday, June 14, 2024, 10:20-11:20 Hall APAD Main Live Demonstration #2

Theme
Sub-theme

Co-sponsor: Cordis / Philips Japan, Ltd.
Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANELOperator
Morinomiya Hospital

EnglishOsamu Iida
Shinsuke Kikuchi
Akiko Tanaka
George Adams
Donghoon Choi
Bryan Yan
Kazuki Tobita
Naoki Fujimura
Wuttichai Saengprakai
Uei Pua
Daizo Kawasaki
CASE 02

Theme;

Short
LectureSpeech
(min)
1.

5

2.

5

3.

5

Title and Speaker
Unlocking the Potential of TRI Through COMFORT Registry
Insights: Strategic Utilization for Future Interventions
Masato Nakamura
Choosing Radial Access: Insights and Evidence from a
Multicenter Study
Amane Kozuki
Revolutionizing Lower Limb Interventions: Insights fromHong Kong's Radial-to-Peripheral Approach
Bryan YanJET 2024 Program Detail
Session No A3
Friday, June 14, 2024, 13:00-14:00 Hall A
PAD Main Live Demonstration #3

Theme
Sub-theme

Co-sponsor: Boston Scientific Japan K.K.
Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
Operator
Tokyo Bay Medical Center

EnglishYoshimitsu Soga
Shigeo Ichihashi
Naoki Yoshioka
Sorracha Rookkapan
Andrej Schmidt
Veera Suwanruangsri
Shuichi Seki
Yoshinori Tsubakimoto
Koen Deloose
Eric Ducasse
Tatsuya Nakama
CASE 03

Theme;

ShortLectureSpeech(min)Title and Speaker

1.

5

Insights from the several nation wide registry in Japan: Whatshould we learn from the current evidence?
Yoshimitsu Soga

2.

5

3.

5

Two-year result from the PROSPECT MONSTER study
Yo Iwata
Safety of the Double Drug Dose for Femoropopliteal
Interventions: Provisional Stenting with Eluvia Drug-Eluting
Stent after Paclitaxel-Coated Balloon Angioplasty
Sabine Steiner

JET 2024 Program Detail
Session No A4Friday, June 14, 2024, 14:10-15:10 Hall A
PAD Main Live Demonstration #4Theme
Sub-theme

Co-sponsor: Medtronic Japan Co., Ltd.

Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
OperatorMorinomiya Hospital

EnglishKenji Suzuki
Masato Nakamura
Takahiro Tokuda
Trakarn ChaivanitPeter Schneider
Nattawut Puangpunngam
Yuki Imoto
Jaroen Cheewinmethasir
Craig M. Walker
Parichart Tanimit
Daizo Kawasaki
CASE 04

Theme;

Short
LectureSpeech(min)
1.

5

2.

5

3.

5Title and Speaker
The Risks of Paclitaxel Safety Concerns: Why There Are
Reasons Not to Use ItPeter Schneider
Expanding the Horizons in DCB Treatment: When TechniqueTranscends Technology (Insights from EAGLE study)
Naoki Hayakawa
Atherectomy plus DCB for complex femoropopliteal lesions
John R. LairdJET 2024 Program Detail
Session No A5
Friday, June 14, 2024, 16:00-17:00 Hall A
PAD Main Live Demonstration #5

Theme
Sub-theme
Co-sponsor: W. L. Gore & Associates G.K. / NIPRO CORPORATION
Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANELOperator
Tokyo Bay Medical CenterEnglish
Masahiko Fujihara
Kazushi Urasawa
Ryoichi Kyuragi
Chia-Hsun Lin
Ralf Langhoff
Hiroki Takahashi
Eiji Karashima
Wuttichai Saengprakai
Chung-Dann Kan
Hsuan Li Huang
Tatsuya Nakama
CASE 05

Theme;

ShortLecture

Speech(min)
1.

5

2.

5

3.

5Title and Speaker
What should we learn from the RELINE MAX study?
Chia-Hsun Lin
Breaking Down the Rumors: The True Limits of DCB
Taku Toyoshima
Stentgraft Solutions: Key Insights from the COYWOLF Study
Yo Iwata

JET 2024 Program Detail
Session No A6Friday, June 14, 2024, 17:10-18:10 Hall A
PAD Main Live Demonstration #6
The future of the drug technology for FP lesions
Co-sponsor: Concept Medical Inc.

Theme
Sub-theme

Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
Operator
Sengkang General
Hospital

EnglishMasahiko Fujihara
Steven Kum
Yo Iwata
Ramon L. Varcoe
Young guk Ko
Andrej Schmidt
Takuya Haraguchi
Sahil Parikh
Chung-Ho Hsu
Taku Kato
Edward Choke
CASE 06

Theme;

Short
LectureSpeech(min)
1.

5

2.

5

3.

5Title and Speaker
Drug Technology in BTK Arteries: Navigating the Limits ofPTX and Unlocking the Potential of Limus
Sahil Parikh
Optimizing Lesion Preparation Before Applying the Drugtechnologies: Identifying the Best Approach
Takuya Haraguchi
What should we learn from the SIRONA trial?
Andrej Schmidt

JET 2024 Program Detail
Session No LBCT2Saturday, June 15, 2024, 08:00-09:00 Hall A
Late Breaking Clinical Trials #2

THEME
Sub-THEME
Language
MODERATOR
MODERATOR
PANEL
PANEL
PANEL
PANEL
PANEL

EnglishTatsuya Nakama
Yann Gouëffic
Terutoshi Yamaoka
Donghoon Choi
Shinsuke Kikuchi
George Liell Adams
Marianne BrodmannSpeech

QA(min)(min)

08:00-5208:07-5208:14-

5208:21-5208:28-

5208:35-

52TimeTitle and Speaker
Insights from the ASPARAGUS study
Mitsuyoshi Takahara
Three-year Outcomes from the POPCORN Registry
Masashi Fukunaga
Recurrent patterns and clinical outcomes after drug-coatedballoon angioplasty for femoropopliteal artery lesions
Naoki Yoshioka
ASsessment of tHerapy for Iatrogenic pseudoaneurysm
including BAlloon-assIsted hemostasis and conveNtionalsUrgical repair: SHIBAINU retrospective multicenter study
Kazuki Tobita
Clinical outcomes following Drug-eluting device forfemoropopliteal lesion : CILANTRO registry
Yusuke Tomoi
Insights from the INFINITY-ISR study
Tatsuya Nakama

JET 2024 Program Detail
Session No A7
Saturday, June 15, 2024, 9:10-10:10 Hall A
PAD Main Live Demonstration #7

Theme
Sub-theme

Co-sponsor: Medtronic Japan Co., Ltd.
Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
Operator
Kokura Memorial Hospital

EnglishTatsuya Nakama
Masato Nakamura
Sayaka Funabashi
John R. Laird
Nattawut Puangpunngam
Ahmed Rafizi Hariz Ramli
Gerard Goh
Amane Kozuki
Riho Suzuki
Takafumi Fujita
Parichart Tanimit
Osamu Iida
CASE 07

Theme;

Short
LectureSpeech(min)
1.

5

2.

5

3.

5Title and Speaker
Drug coated balloons for femoropopliteal disease - what'sthe latest.
John R. Laird
Deciphering IVUS-Detected Dissections: Delineating theThreshold of Malignancy
Amane Kozuki
Randomized trial comparing a stent-avoiding with a stentpreferred strategy in complex femoropopliteal lesions(BEST SFA study): 2 year outcome data
Sabine Steiner

JET 2024 Program Detail
Session No A8
Saturday, June 15, 2024, 10:20-11:20 Hall A
PAD Main Live Demonstration #8

Theme
Sub-theme

Co-sponsor: Medicon, Inc / Philips Japan, Ltd.
Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
Operator
Kishiwada Tokushukai
Hospital

EnglishMakoto Sugihara
Hiroshi Ando
Kenji Ogata
Naoto Inoue
I-Ming Chen
Mariano Palena
Andrej Schmidt
Yusuke Tomoi
Takenobu Shimada
Sorracha Rookkapan
Su Hong Kim
Masahiko Fujihara
CASE 08

Theme;

Short
LectureSpeech(min)
1.

5

2.

5

3.

5Title and Speaker
Maximizing Impact with UltraScore: Unveiling the Pinnacleof Scoring Systems
Mariano Palena
Insights from the SAFE registry; what is the definition of the"optimal" vessel prep
Andrej Schmidt
When should we set the stent in femoropopliteal segment?
Yusuke TomoiJET 2024 Program Detail
Session No A9
Saturday, June 15, 2024, 12:40-13:40 Hall A
PAD Main Live Demonstration #9

Theme
Sub-theme

Co-sponsor: Boston Scientific Japan K.K.
NIPRO CORPORATION

Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
Operator
Kishiwada Tokushukai
Hospital

EnglishKenji SuzukiNobuyoshi Azuma
Sayaka Funabashi
Naoto Inoue
Saritphat Orrapin
Yin Chun Skyi Pang
Shigeo Ichihashi
Takehiro Yamada
Darryl Lim Mingjun
YueHong Zheng
Nicolas Louis
Masahiko Fujihara
CASE 09

Theme;

Short
LectureSpeech
(min)
1.

5

2.

5

3.

5Title and Speaker
Navigating DCB Limitations and DES Applications through
IVUS Insights
Kazunori Horie
IVUS in peripheral interventions: from the evidence-based
review to clinical practice in Thailand
Saritphat Orrapin
DES/DCB/BMS: What Do Single-Arm and Comparative Trials
Teach Us
Marianne Brodmann

JET 2024 Program DetailSession No A10
Saturday, June 15, 2024, 13:50-14:50 Hall A
PAD Main Live Demonstration #10

Theme
Sub-theme
Co-sponsor: Philips Japan, Ltd. / Medico's Hirata Inc.
Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
Operator
Kokura Memorial Hospital

EnglishTatsuya Nakama
Kazushi Urasawa
Kei Ichihashi
Craig M. Walker
Koen Deloose
Shannon D. Thomas
Masataka Yoshinaga
Su Hong Kim
Yoshito Yamamoto
Prakash Krishnan
Yoshimitsu Soga
CASE 10

Theme;

Short
LectureSpeech(min)
1.

52.

5

3.

5Title and Speaker
Optimizing Strategies for Stent Failure in Femoropopliteal
Lesions: A Comprehensive Approach
Craig M. Walker
FINAL 5-year data of the T.I.N.T.I.N. Trial: Luminor DCB andinvolution stent in TASC C and D femoropopliteal
atherosclerotic disease
Koen Deloose
Insights from the INFINITY ISR registry; Does the OFDI
change the "games" in ISR lesions?
Tatsuya Nakama

JET 2024 Program Detail
Session No A11
Saturday, June 15, 2024, 15:40-16:40 Hall A
PAD Main Live Demonstration #11

Theme
Sub-theme
Co-sponsor: W. L. Gore & Associates G.K. / KANEKA MEDICAL PRODUCTS.
Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANELOperator
Kishiwada Tokushukai
Hospital

EnglishTakao Ohki
Tatsuya Nakama
Taku Kato
Edward Choke
Ralf Langhoff
Chung-Dann Kan
Yuki ShimaDonghoon Choi
Shinsuke Kikuchi
I-Ming Chen
Masahiko Fujihara
CASE 11

Theme;

Short
LectureSpeech
(min)
1.

5

2.

5

3.

5Title and Speaker
Insights from the AVOCAD and AVOCAD II
Yusuke Tomoi
Delivering the Most Reliable Stents from the Safest Access
Sites
Kenji Suzuki
How should we treat Recurrence of AI lesions: Insights fromthe multicenter study?
Takahiro Tokuda

JET 2024 Program Detail
Session No A12
Saturday, June 15, 2024, 16:50-17:50 Hall A
PAD Main Live Demonstration #12

Theme
Sub-theme

Co-sponsor: KANEKA MEDICAL PRODUCTS.
Language
MODERATOR
MODERATORFACILITATOR
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
PANEL
Operator
Kokura Memorial Hospital

EnglishNobuhiro Suematsu
Makoto Sugihara
Taku Toyoshima
Roberto Ferraresi
Shannon D. Thomas
Steven Kum
Yusuke Sato
Hideyuki Takimura
Hsuan Li Huang
Pankaj Jha
Yoshimitsu Soga
CASE 12Theme;

Short
LectureSpeech(min)1.

5

2.

5

3.

5

Title and Speaker
Assessing the Necessity of Drug Technology in BTK Disease:
A Comprehensive Overview
Yo Iwata
Transforming the Horizon: The Impact of the LIFE BTK Trial
Results in CLTI management
Ramon L. Varcoe
High-pressure balloon and block technique is the evolution
for the BTK interventions
Steven Kum